Signaling pathways in rheumatoid arthritis: implications for targeted therapy DOI Creative Commons
Qian Ding, Wei Hu, Ran Wang

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: Feb. 17, 2023

Abstract Rheumatoid arthritis (RA) is an incurable systemic autoimmune disease. Disease progression leads to joint deformity and associated loss of function, which significantly impacts the quality life for sufferers adds losses in labor force. In past few decades, RA has attracted increased attention from researchers, abnormal signaling pathways are a very important research field diagnosis treatment RA, provides evidence understanding this complex disease developing novel RA-linked intervention targets. The current review intends provide comprehensive overview including general introduction disease, historical events, epidemiology, risk factors, pathological process, highlight primary progress various molecular mechanisms, genetic epigenetic summarize most recent developments identifying new inhibitors treating RA. therapeutic interventions approved drugs, clinical pre-clinical cutting-edge technologies. These will hopefully drive strategically targeted therapies hope ideas options future.

Language: Английский

Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-κB pathway quenches intestinal inflammation and oxidative stress injury DOI Creative Commons
Mingxia Zhou, Weimin Xu, Jiazheng Wang

et al.

EBioMedicine, Journal Year: 2018, Volume and Issue: 35, P. 345 - 360

Published: Aug. 29, 2018

Background and aimsDefective autophagy has been proposed as an important event in a growing number of autoimmune inflammatory diseases such rheumatoid arthritis lupus. However, the precise role mechanistic target rapamycin (mTOR)-dependent its underlying regulatory mechanisms intestinal epithelium response to inflammation oxidative stress remain poorly understood.MethodsThe levels p-mTOR, LC3B, p62 mice LPS-treated cells were examined by immunoblotting, immunohistochemistry, confocal microscopy transmission electron (TEM). We evaluated expression IL-1β, IL-8, TNF-α, MDA, SOD T-AOC quantitative real time-polymerase chain reaction (qRT-PCR) commercially available kits after silencing mTOR ATG5. In vivo modulation was achieved using AZD8055, 3-methyladenine. Finally, verify involvement TLR4 signalling NF-κB pathway active ulcerative colitis (UC) patients, immunofluorescence, qRT-PCR, immunoblotting TEM performed determine relevance inflammation.ResultsThe mTOR-dependent autophagic flux impairment murine model colitis, human epithelial UC patients is probably regulated TLR4-MyD88-MAPK pathway. Silencing remarkably attenuated, whereas inhibiting ATG5 aggravated, LPS-induced injury. Pharmacological administration inhibitors stimulators markedly ameliorated experimental vivo.ConclusionsOur findings not only shed light on mechanism autophagy, but also provided potential therapeutic targets for refractory bowel disease.

Language: Английский

Citations

273

Neuroinflammation in Alzheimer’s disease DOI Creative Commons

Fengjin Zhang,

Jiang Lin-lan

Neuropsychiatric Disease and Treatment, Journal Year: 2015, Volume and Issue: unknown, P. 243 - 243

Published: Jan. 1, 2015

Abstract: Amyloid-β plaques and neurofibrillary tangles are the main neuropathological hallmarks in Alzheimer’s disease (AD), most common cause of dementia elderly. However, it has become increasingly apparent that neuroinflammation plays a significant role pathophysiology AD. This review summarizes current status research related to AD, focusing on connections between some inflammation factors Among these connections, we discuss dysfunctional blood–brain barrier alterations functional responses microglia astrocytes this process. In addition, summarize intracellular signaling pathways involved inflammatory microglia, including mitogen-activated protein kinase pathways, nuclear factor-kappa B cascade, peroxisome proliferator–activated receptor-gamma transcription factors. Finally, dysregulation control release pro- anti-inflammatory cytokines classic AD pathology (amyloid tangles) is also reviewed. Keywords: inflammation, barrier, glial cells,

Language: Английский

Citations

250

Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease DOI
Mojtaba Golpich, Elham Amini, Fatemeh Hemmati

et al.

Pharmacological Research, Journal Year: 2015, Volume and Issue: 97, P. 16 - 26

Published: April 6, 2015

Language: Английский

Citations

238

Therapeutic Potential of Volatile Terpenes and Terpenoids from Forests for Inflammatory Diseases DOI Open Access
Taejoon Kim, Bokyeong Song, Kyoung Sang Cho

et al.

International Journal of Molecular Sciences, Journal Year: 2020, Volume and Issue: 21(6), P. 2187 - 2187

Published: March 22, 2020

Forest trees are a major source of biogenic volatile organic compounds (BVOCs). Terpenes and terpenoids known as the main BVOCs forest aerosols. These have been shown to display broad range biological activities in various human disease models, thus implying that aerosols containing these may be related beneficial effects bathing. In this review, we surveyed studies analyzing selected most abundant 23 terpenes emitted forested areas Northern Hemisphere, which were reported anti-inflammatory activities. We categorized processes functions into six groups summarized their molecular mechanisms action. Finally, among compounds, examined therapeutic potentials 12 effective against respiratory inflammation, atopic dermatitis, arthritis, neuroinflammation inflammatory diseases. conclusion, updated support propose potential use chemopreventive agents for treating

Language: Английский

Citations

219

Signaling pathways in rheumatoid arthritis: implications for targeted therapy DOI Creative Commons
Qian Ding, Wei Hu, Ran Wang

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: Feb. 17, 2023

Abstract Rheumatoid arthritis (RA) is an incurable systemic autoimmune disease. Disease progression leads to joint deformity and associated loss of function, which significantly impacts the quality life for sufferers adds losses in labor force. In past few decades, RA has attracted increased attention from researchers, abnormal signaling pathways are a very important research field diagnosis treatment RA, provides evidence understanding this complex disease developing novel RA-linked intervention targets. The current review intends provide comprehensive overview including general introduction disease, historical events, epidemiology, risk factors, pathological process, highlight primary progress various molecular mechanisms, genetic epigenetic summarize most recent developments identifying new inhibitors treating RA. therapeutic interventions approved drugs, clinical pre-clinical cutting-edge technologies. These will hopefully drive strategically targeted therapies hope ideas options future.

Language: Английский

Citations

217